Neema Lakshman's Colleagues at Audentes Therapeutics
Malou Gemeniano
Executive Director of Regulatory CMC, Astellas Gene Therapies
Neema Lakshman's Contact Details
(415) 818-1005
San Ramon, California, United States
Audentes Therapeutics
Neema Lakshman's Company Details
Audentes Therapeutics is a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases. We are leveraging our AAV gene therapy technology platform and proprietary manufacturing expertise to develop programs across three modalities: gene replacement, vectorized exon skipping, and vectorized RNA knockdown. Our product candidates are showing promising therapeutic profiles in clinical and preclinical studies across a range of neuromuscular diseases. Audentes is a focused, experienced and passionate team driven by the goal of improving the lives of patients. If you are interested in learning more about our company, please do not hesitate to contact us.